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1182-160 Increased Heart Failure Hospitalization Rate in Smokers 
Is Mediated by Preceding lechemic Events in Patients 
With Heart Fai lure and Left  Ventricular Dysfunction in 
SOLVD 
Raviorasad G. Subrava. Clifton R. Lacy, Alan C. Wilson, Jyothi Raviprasad, John B. 
Kostis, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey. 
Background: Smoking has bean demonstrated to increase rates of hospitalization due to 
heart failure (HF) in patients (pts) with heart failure or left ventricular dysfunction (LVD). 
Whether smoking exerts this effect through ischemic events has not been well established. 
Methods: We studied 6797 pts; 2569 pts in the Treatment Trial (T; LVD with HF) and 4228 
pts in the Prevention Trial (P; LVD without HF) of the Studies of Left Ventricular Dysfunction 
(SOLVD). We evaluated hospitalization due to HF preceded by ischemic events (myocar- 
dial infarction or angina requiring hospitalization), over an average follow-up of 41.4 
months in T and 37.4 months in P, comparing pts who were current smokers to non-smok- 
ers at baseline. Ischemic etiology accounted for 71% of HF pts in the T trial and 83% of 
LVD pts in the P trial. Current smokers accounted for 23% in the Combined Trials (T+P), 
24% in the P Tdal and 22% in the T Trial. 
Results: After adjusting for age, gender, race, ejection fraction, atrial fibrillation, alcohol 
consumption, NYHA class, hypertension, diabetes mellitus, previous myocardial infarction, 
angina, etiology of left ventricular dysfunction, revasculadzation and medications, smokers 
had significantly higher hospitalization rates preceded by ischemic events in all pts in the 
Combined Trials (RR=1.59, p=0.003) and in the Prevention Trial (RR=1.86, p=O.O05), and 
non-significantly higher hospitalization rate in the Treatment Tnal (RR=1.39, p=0.14). 
Smoking did not significantly affect hospitalization rate for HF in patients that did not have 
preceding ischemic events. 
Conoluelon: The increase in hospitalization rate for heart failure in smokers in SOLVD is 
mediated by preceding ischemic events. 
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1183-147 Electron Beam Computed Tomography and Cardiac 
Transplant 
Norman B. Ratliff. III, Marc R. Pritzker, Charles R. Jorgensen, Fredarick L. Gobel, 
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, University of 
Minnesota, Minneapolis, Minnesota. 
Background: Coronary ellograft vasculopathy (CAV) is the leading cause of morbidity and 
mortality in cardiac transplant recipients surviving >1 year. Non-invasive diagnostic meth- 
ods have generally been insensitive. Recently, electron beam computed tomography 
(EBCT) was suggested to have a high negative predictive value but the data are sparse. 
Methods: 55 patients (13 female,42 male) underwent coronary aogiography and EBCT at a 
mean of 8 years after cardiac transplantation. The angiographic and EBCT data were 
reviewed separately in a blinded fashion. A coronary index score (CI) between 1 and 100 
(100=normal) was calculated for each angiogram. The CI was bedved using a combination 
of the BARI definitions and the National Heart and Chest Hospital algorithm. In these sys- 
tems serial lesions multiply, parallel lesions add and vessels are weighted according to the 
amount of myocardium supplied. Individual esions were rated according to length of artery 
wall involvement as welt as luminal diameter narrowing. This method more accurately 
reflects the diffuse nature of CAV as opposed to focusing solely on severe stenoses. An 
EBCT score of >0 was considered abnormal. 
Results: Twenty-seven patients had an EBCT score of zero. Thirty-six patients had a CI 
score of 100. Using the CI as the standard, EBCT resulted in 13 true positives, 14 false 
positives, 22 true negatives and 6 false negatives. The sensitivity of EBCT was 68%, the 
specificity was 61%. The disease prevalence was 35% so the accuracy was 64%. The pos- 
itive predictive value of EBCT was 48% with a median EBCT score of 6.6 in the false posi- 
tives and 70.5 in the true positives. The negative predictive value of EBCT was 79% with CI 
score ranging from 19-69 in the false negatives, These predictive values are substantially 
lower than in previous reports. Six patients had an EBCT score of zero despite having a 
mean CI score of 45. These patients were a median of 11 years post transplantation. Four- 
teen patients had a CI score of 100 despite having a median EBCT score of 10.7. 
Conclusions: EBCT has low accuracy and predictive value for angiographic coronary artery 
disease in long-term cardiac transplant survivors. 
1183-148 Shrinkage of Allograft Vessels Early After 
Transplantation Is Independent of Plaque Progression 
and Associated With Myocardial Fibrosis: A Serial 
Histologic and Volumetric Intravascular Ultrasound 
Study 
Showkat A. Hail Mohamad H. Yamani, Randall C. Starling, Paul Schoechagen, Samir 
Kapadia, Timothy D. Crewe, Norman B. Ratliff, James B. Young, E. Murat Tuzcu, The 
Cleveland Clinic Foundation, Cleveland, Ohio. 
Shrinkage of allograft vessels has been described early after transplantation. The mecha- 
nisms are incompletely understood. 
Methods: We examined 66 consecutive patients at 1 month and one year after transplanta- 
tion with sedal Intravascular Ultrasound (IVUS), using an automated pullback system 
(O.5mm/sec). Matched segments of the proximal LAD (average length 20ram) were identi- 
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fled. Using serial volumetdc analysis (evenly spaced images tram apart), the lumen (L), 
vessel wall (EEM) and plaque (P=EEM-L) volumes were manually measured and average 
change in volumes was calculated. Sedal endomyocardial biopsies during the first year of 
transplantation were examinod for cellular rejection, vascular rejection, post transplant 
ischamia and fibrosis. Ischemic injury related to transplantation was identified by areas of 
myocyte necrosis occurdng in the immediate post-transplant pedod with an absence of 
infiltration by activated lymphocytes. Interstitial myocardial fibrosis within a few weeks after 
transplantation, readily identified on H and E staining and after excluding scarring consis- 
tent with old biopsy site was considered consistent with ischemic- fibrotic injury. 
Results: Expansion of vessel walt at one year was identified in 35/66 (53%) patients (Group 
A) and vessel wall shdnkoge was seen in 31/66 (47%) patients (Group B). While patients in 
group A showed significant increase in average plaque volume, patients in group B 
showed no increase in plaque (1.14 Vs 0.15 mm3/mm, p= 0.004). The incidence of post 
transplant myocardial ischemic-fibretic injury was significantly higher in group B patients 
compared to group A (32% Vs 3 %, p=0.001 ). There was no significant difference between 
the number of rejection episodes in the two groups. 
Conclusion: In cardiac allograft vessels early shrinkage is independent of plaque progres- 
sion and is associated with post transplant myocardial ischemic-fibrotic injury. 
1183-149 Percutaneoua Catheter Interventions for Cardiac 
Transplant Patients 
Yuzuru Takano. Oren T. Guttman, Jesse W. Currier, Lawrence A. Yeatman, Jon A. 
Kobashigewa, Danie~ Marel]i, Mark Grise, James R. Higgins, Jonathan M Tobis, UCLA 
Center for Health Sciences, Los Angeles, California. 
Background. Accelerated allograff arteriopathy limits the survival of patients who 
undergo orthotopic heart transplantion (OHT). Percutaneous catheter interventions (PCI) 
for stenoses in OHT patients was analyzed for the effect on graft survival and restsnosis. 
Methods. The study included 103 coronary artery lesions from 50 interventional proce- 
dures in 35 patients who had OHT and were referred for PCI between July 1993-June 
2001. The patients had yearly angiographic follow up for rsstsnosis. 
Results. The mean time after transplant was 6.2+3.3 yrs. The procedural success rate 
was 93%, defined as a post procedural lumen diameter stenosis <50% without a major 
complication. The baseline MLD was 0.61~0.6 mm and improved to 2.5_+0.8 mm post pro- 
cedure. The % diameter stenosis decreased from 79.8:1:19.3% at baseline to 
13.0~-15,4%. Coronary stenting was performed in 55 lesions (57%). Angiographic follow 
up in 57 lesions at 9.0±7.2 months showed a mean MLD of 1.4±1.2 mm, a % diameter 
stenosis of 49.4+40.5% and a restenosis rate of 44%. The allograft survival rate was 
51% at 5 years after intervention (repeat OHT 9, death 3). 
Conclusions. PCI can be an effective and safe method of treatment for ailograft artedop- 
athy, or act as a temporizing measure until repeat OHT in patients with diffuse artedopa- 
thy. The an~iographic rsstenosis rate remains high, even in stented lesions. 
Cardiac Transplant PCI Stent No Stent p value 
# of lesions 55 41 
Reference diameter (ram) 2.9-3:0.6 2.7i-0.5 n.s. 
Lesion length (mm) 14.9+7.4 14.7~.7 n.s. 
MLD (rnm) before 0.7+0.6 0.4:L-0.5 p<0.05 
after PCI 2.9±0.7 2.0!0.5 p<0.O001 
Restenosis rate (%) 37 52 p=0.25 
1183-150 Novel Noninvasive Strategy for  Cardiac A l lograf t  
Vasculopathy Surveillance and Timing of Cardiac 
Catheterizations in Heart Transplant Recipients 
Michael Dandel, Friedrich Knollmann, Manfred Hummel, Ernst Wellnhofer, Johannes 
MOiler, Roland Hefzer, Deutsches Herzzentrum Berlin, Bedin, Germany, Strahlenklinik, 
Chadte, Campus Virchow-K/inikum, Berlin, Germany. 
Background: With routine annual coronary engiography for transplant coronary artery 
disease (TxCAD) surveillance there are dsks of major complications including renal fail- 
ure because of chronic renal impairment due to cyclosporins. After promising results with 
regard to the noninvasive TxCAD diagnosis by electron beam computed tomography 
[EBCT] and pulsed tissue Doppler imaging [PW-TDI], we assessed the usefulness of a 
combined monitoring for TxCAD diagnosis using EBCT and PW-TDI together, 
Methods: Throughout a testing pedod of 18 months, 196 heart recipients (post-transplant 
time: 1-16 years) underwent PW-TDI (for wall motion assessment) and EBCT (to detect 
coronary calcifications) before cardiac catheterization. With PW-TDI we measured the 
peak systolic and early diastolic wall motion velocities Sm and Ern, the systolic and dias- 
tolic times TSm (from onset of the first heart sound to Sin) and TErn (from onset of the 
second heart sound to Era), as well as the systolic and eady diastolic wall accelerations 
Sm/TSm and Em/'l'Em. Coronary calcifications were quantified by the Agatston scoring 
system. EBCT and PW-TDI data were tested for relationships with angiographic findings. 
Results: The systolic peak wall motion velocity (Sin) and the Agatston score (AS) 
showed high diagnostic values for TxCAD. We found highly significant differences 
(p=0.0001) between patients with and without proximal stenoses of the great epicardial 
coronary vessels for both the AS and Sin. Definite cut-off values for AS and Sm enabled 
highly diagnostic conclusions. The high negative predictive values for relevant coronary 
stenoses of Sm values below 9 cm/s (91.0%) and AS values below 50 (91.1%) allow cor- 
onary stecoses exclusion with high probability. Using both Sm and AS we obtained sev- 
eral functions that enable a diagnostic decision with similar probabilities of about 87 to 
90%. Among these, Fisher's classification functions appeared most suitable for patient 
selection to coronary angiography on the base of PW-TDI and EBCT findings. 
Conclusions: Serial PW-TDI and annual EBCT are reliable for timing of cardiac catheter- 
izations and enable patients with high-risk for catheterization, to be spared routine 
angiographies. 
